Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0013 | 0.0125 | 0.0195 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.001 | 0.0003 | 0.0017 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0016 | 0.0208 | 0.1155 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0326 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0653 | 0.1736 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0326 | 0.1333 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0049 | 0.1342 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0013 | 0.0125 | 0.1258 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0326 | 0.5981 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0326 | 0.0508 |
Brugia malayi | mbt repeat family protein | 0.0049 | 0.1342 | 0.8525 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0326 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0013 | 0.0125 | 0.5 |
Brugia malayi | Thioredoxin reductase | 0.0039 | 0.0995 | 0.6319 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0039 | 0.1013 | 0.158 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0021 | 0.0379 | 0.3811 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0326 | 0.0866 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0326 | 0.0326 |
Onchocerca volvulus | 0.0049 | 0.1342 | 0.5 | |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0.0653 | 0.3257 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0326 | 0.2531 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0653 | 0.6185 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0049 | 0.1342 | 0.2094 |
Trypanosoma brucei | trypanothione reductase | 0.0039 | 0.0995 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0098 | 0.3039 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0088 | 0.27 | 0.8837 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0326 | 0.2068 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0088 | 0.27 | 0.8837 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.0019 | 0.0307 | 0.0307 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.1575 | 0.4185 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0013 | 0.0125 | 0.0693 |
Toxoplasma gondii | thioredoxin reductase | 0.0039 | 0.0995 | 0.5526 |
Loa Loa (eye worm) | MBCTL1 | 0.0056 | 0.1575 | 0.4185 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0056 | 0.1575 | 0.1575 |
Brugia malayi | glutathione reductase | 0.0039 | 0.0995 | 0.6319 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0039 | 0.0995 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0013 | 0.0125 | 0.0154 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0013 | 0.0125 | 0.0293 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0019 | 0.0326 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0062 | 0.18 | 1 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0013 | 0.0125 | 0.0693 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0013 | 0.0125 | 0.1258 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0088 | 0.27 | 0.8837 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0029 | 0.0653 | 0.6069 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0049 | 0.1342 | 0.1342 |
Echinococcus granulosus | bloom syndrome protein | 0.0024 | 0.0478 | 0.0746 |
Mycobacterium tuberculosis | Probable reductase | 0.0088 | 0.27 | 0.8837 |
Loa Loa (eye worm) | RecQ helicase | 0.0024 | 0.0478 | 0.1271 |
Plasmodium falciparum | glutathione reductase | 0.0039 | 0.0995 | 1 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0098 | 0.3039 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.18 | 1 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0197 | 0.6411 | 1 |
Leishmania major | trypanothione reductase | 0.0039 | 0.0995 | 0.5266 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0326 | 0.1197 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0039 | 0.1013 | 0.158 |
Brugia malayi | hypothetical protein | 0.0029 | 0.0653 | 0.4147 |
Plasmodium vivax | glutathione reductase, putative | 0.0039 | 0.0995 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.18 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0326 | 0.1809 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.001 | 0.0003 | 0.0017 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0062 | 0.18 | 1 |
Brugia malayi | hypothetical protein | 0.0019 | 0.0302 | 0.1921 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0326 | 0.2531 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0013 | 0.0125 | 0.0293 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0049 | 0.1342 | 0.2094 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.0108 | 0.0108 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0056 | 0.1575 | 0.2456 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0062 | 0.18 | 0.2808 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0013 | 0.0125 | 0.0293 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0039 | 0.0995 | 0.2985 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0013 | 0.0125 | 0.0293 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0013 | 0.0125 | 0.0795 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0197 | 0.6411 | 1 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0013 | 0.0125 | 0.0154 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.18 | 0.18 |
Brugia malayi | mbt repeat family protein | 0.0049 | 0.1342 | 0.8525 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0326 | 0.0508 |
Echinococcus multilocularis | bloom syndrome protein | 0.0024 | 0.0478 | 0.0746 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.0016 | 0.0214 | 0.1026 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0056 | 0.1575 | 0.2456 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0154 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1342 | 0.3568 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0154 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0013 | 0.0125 | 0.0695 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.00000000015305 | 0.00000000085013 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0013 | 0.0125 | 0.0695 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0653 | 0.6564 |
Brugia malayi | Bloom's syndrome protein homolog | 0.0024 | 0.0478 | 0.3036 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0.0653 | 0.6564 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0088 | 0.27 | 0.8837 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0049 | 0.1342 | 0.1342 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0049 | 0.1342 | 0.2094 |
Plasmodium falciparum | thioredoxin reductase | 0.0013 | 0.0125 | 0.1258 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0098 | 0.3039 | 1 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0049 | 0.1342 | 0.1342 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0062 | 0.18 | 0.18 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0326 | 0.0688 |
Loa Loa (eye worm) | glutathione reductase | 0.0039 | 0.0995 | 0.2645 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0013 | 0.0125 | 0.3843 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0326 | 0.5981 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0029 | 0.0653 | 0.3627 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0326 | 0.2305 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0056 | 0.1575 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0013 | 0.0125 | 0.0195 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0013 | 0.0125 | 0.0293 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0013 | 0.0108 | 0.0168 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0049 | 0.1342 | 0.2094 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0062 | 0.18 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0039 | 0.0995 | 0.2645 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0326 | 1 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0013 | 0.0108 | 0.0168 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0029 | 0.0653 | 0.6185 |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 0.3762 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0013 | 0.0125 | 0.0125 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0029 | 0.0653 | 0.6185 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0062 | 0.18 | 0.2808 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0056 | 0.1575 | 0.2456 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0024 | 0.0478 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0013 | 0.0125 | 0.0293 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0088 | 0.27 | 0.8837 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0056 | 0.1575 | 0.2456 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0062 | 0.18 | 0.575 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0098 | 0.3039 | 1 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0024 | 0.0478 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0326 | 0.3273 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0039 | 0.0995 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0039 | 0.0995 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0326 | 0.0326 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0013 | 0.0125 | 0.1258 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0326 | 0.2531 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0049 | 0.1342 | 0.3568 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 2 % | Inhibition of human DNA topoisomerase 2 alpha assessed as inhibition of supercoiled pBR322 DNA relaxation at 100 uM after 30 mins by gel electrophoresis | ChEMBL. | 21601964 |
Inhibition (binding) | = 11.5 % | Inhibition of human recombinant DNA topoisomerase 1 assessed as inhibition of supercoiled pBR322 DNA relaxation at 100 uM after 30 mins by gel electrophoresis | ChEMBL. | 21601964 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.